SI · Shoulder Innovations Inc. Common Stock
View on chartInsiders & Stakes
| Gilde Healthcare Holding B.V. | ▼ Sell | Open Market | 2,185,914 Shares held | 8/26/2026 | View profile |
| LSV Associates II, LLC | ▲ Buy | Open Market | 1,885,136 Shares held | 8/1/2025 | View profile |
| Ball Robert Joseph CEO & EXECUTIVE CHAIRMAN | ▼ Sell | Open Market | 380,824 Shares held | 9/14/2026 | View profile |
| Ahearn Matthew Fraser CHIEF OPERATING OFFICER | ▼ Sell | Open Market | 244,176 Shares held | 8/18/2026 | View profile |
| Blue David Lawrence SEE REMARKS | ▲ Buy | Grant | 139,372 Shares held | 12/31/2025 | View profile |
| Points Jeffrey S. CHIEF FINANCIAL OFFICER | ▲ Buy | Open Market | 70,785 Shares held | 3/13/2026 | View profile |
| Paul Buckman Director | ▲ Buy | Grant | 65,025 Shares held | 10/5/2026 | View profile |
| Casey M. Tansey Director | ▲ Buy | Grant | 53,445 Shares held | 10/5/2026 | View profile |
| Sidow Kevin K. Director | ▲ Buy | Grant | 25,948 Shares held | 10/5/2026 | View profile |
| Buchholz Richard Director | ▲ Buy | Grant | 18,712 Shares held | 6/26/2026 | View profile |
| Carusi Michael A Director | ▲ Buy | Grant | 7,666 Shares held | 8/1/2025 | View profile |
| Pardo Geoffrey B Director | ▲ Buy | Grant | 7,666 Shares held | 8/1/2025 | View profile |
| Hykes Andrew Director | ▲ Buy | Grant | 7,438 Shares held | 10/5/2026 | View profile |
Transaction History
| Casey M. Tansey | ▲ Buy | Grant | 733 | $14K | 10/5/2026 |
| Sidow Kevin K. | ▲ Buy | Grant | 892 | $17K | 10/5/2026 |
| Hykes Andrew | ▲ Buy | Grant | 669 | $13K | 10/5/2026 |
| Paul Buckman | ▲ Buy | Grant | 1,275 | $25K | 10/5/2026 |
| Ball Robert Joseph | ▲ Buy | Option Exercise | 89,233 | $187K | 9/14/2026 |
| Ball Robert Joseph | ▼ Sell | Open Market | 10,175 | $188K | 9/14/2026 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Open Market | 1,196 | $27K | 8/26/2026 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Open Market | 681 | $15K | 8/24/2026 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Open Market | 20,516 | $464K | 8/21/2026 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Open Market | 3,900 | $88K | 8/20/2026 |
| Ahearn Matthew Fraser | ▼ Sell | Open Market | 12,586 | $263K | 8/18/2026 |
| Ahearn Matthew Fraser | ▼ Sell | Open Market | 1,600 | $34K | 8/18/2026 |
| Ahearn Matthew Fraser | ▼ Sell | Open Market | 8,314 | $167K | 8/17/2026 |
| Ahearn Matthew Fraser | ▼ Sell | Gift | 2,500 | $0 | 8/14/2026 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Open Market | 2,095 | $47K | 8/6/2026 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Open Market | 7,338 | $166K | 8/5/2026 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Open Market | 99,812 | $2.3M | 8/4/2026 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Open Market | 10,751 | $244K | 8/3/2026 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Open Market | 20,034 | $455K | 7/31/2026 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Open Market | 28,245 | $660K | 7/30/2026 |
| Buchholz Richard | ▲ Buy | Grant | 5,046 | $0 | 6/26/2026 |
| Paul Buckman | ▲ Buy | Grant | 5,046 | $0 | 6/26/2026 |
| Sidow Kevin K. | ▲ Buy | Grant | 5,046 | $0 | 6/26/2026 |
| Hykes Andrew | ▲ Buy | Grant | 5,046 | $0 | 6/26/2026 |
| Casey M. Tansey | ▲ Buy | Grant | 5,046 | $0 | 6/26/2026 |
| Ahearn Matthew Fraser | ▼ Sell | Open Market | 1,644 | $30K | 6/15/2026 |
| Ahearn Matthew Fraser | ▼ Sell | Open Market | 2,500 | $48K | 6/15/2026 |
| Ahearn Matthew Fraser | ▼ Sell | Open Market | 15,856 | $296K | 6/12/2026 |
| Ball Robert Joseph | ▲ Buy | Option Exercise | 10,000 | $25K | 4/30/2026 |
| Ahearn Matthew Fraser | ▲ Buy | Option Exercise | 7,421 | $18K | 4/20/2026 |
| Ahearn Matthew Fraser | ▲ Buy | Option Exercise | 14,243 | $41K | 4/20/2026 |
| Paul Buckman | ▼ Sell | Tax Withholding | 3,292 | $48K | 3/13/2026 |
| Paul Buckman | ▼ Sell | Tax Withholding | 3,714 | $55K | 3/13/2026 |
| Points Jeffrey S. | ▲ Buy | Open Market | 2,000 | $30K | 3/13/2026 |
| Paul Buckman | ▲ Buy | Option Exercise | 19,401 | $48K | 3/13/2026 |
| Buchholz Richard | ▲ Buy | Open Market | 1,000 | $15K | 3/13/2026 |
| Points Jeffrey S. | ▲ Buy | Option Exercise | 13,264 | $33K | 3/13/2026 |
| Ball Robert Joseph | ▲ Buy | Open Market | 2,200 | $33K | 3/13/2026 |
| Paul Buckman | ▲ Buy | Option Exercise | 26,205 | $55K | 3/13/2026 |
| Ball Robert Joseph | ▲ Buy | Option Exercise | 10,000 | $25K | 2/6/2026 |
| Ball Robert Joseph | ▲ Buy | Option Exercise | 2,062 | $4K | 2/6/2026 |
| Points Jeffrey S. | ▲ Buy | Grant | 1,076 | $13K | 12/31/2025 |
| Blue David Lawrence | ▲ Buy | Grant | 1,041 | $13K | 12/31/2025 |
| Ball Robert Joseph | ▲ Buy | Grant | 1,661 | $20K | 12/31/2025 |
| Ahearn Matthew Fraser | ▲ Buy | Grant | 477 | $6K | 12/31/2025 |
| Points Jeffrey S. | ▲ Buy | Open Market | 1,005 | $15K | 12/12/2025 |
| Ball Robert Joseph | ▲ Buy | Open Market | 3,900 | $58K | 12/12/2025 |
| Points Jeffrey S. | ▲ Buy | Open Market | 995 | $15K | 12/11/2025 |
| Ball Robert Joseph | ▲ Buy | Open Market | 3,300 | $49K | 12/11/2025 |
| Points Jeffrey S. | ▲ Buy | Open Market | 1,600 | $25K | 9/12/2025 |
| Blue David Lawrence | ▲ Buy | Option Exercise | 78,616 | $165K | 9/12/2025 |
| Blue David Lawrence | ▲ Buy | Option Exercise | 15,778 | $39K | 9/12/2025 |
| Ball Robert Joseph | ▲ Buy | Open Market | 6,000 | $93K | 9/12/2025 |
| Points Jeffrey S. | ▲ Buy | Option Exercise | 13,264 | $33K | 9/11/2025 |
| Ball Robert Joseph | ▲ Buy | Open Market | 2,000 | $30K | 9/11/2025 |
| Ahearn Matthew Fraser | ▲ Buy | Option Exercise | 12,286 | $11K | 9/11/2025 |
| Ahearn Matthew Fraser | ▲ Buy | Option Exercise | 78,616 | $165K | 9/11/2025 |
| Ahearn Matthew Fraser | ▲ Buy | Option Exercise | 16,443 | $41K | 9/11/2025 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Other | 1,743,156 | — | 8/1/2025 |
| Gilde Healthcare Holding B.V. | ▼ Sell | Other | 537,326 | — | 8/1/2025 |
| Gilde Healthcare Holding B.V. | ▲ Buy | Open Market | 100,000 | $1.5M | 8/1/2025 |
| Carusi Michael A | ▼ Sell | Other | 1,618,470 | — | 8/1/2025 |
| Carusi Michael A | ▲ Buy | Open Market | 266,666 | $4.0M | 8/1/2025 |
| Carusi Michael A | ▲ Buy | Grant | 7,666 | $0 | 8/1/2025 |
| Ball Robert Joseph | ▼ Sell | Other | 85,888 | — | 8/1/2025 |
| Buchholz Richard | ▲ Buy | Grant | 7,666 | $0 | 8/1/2025 |
| Buchholz Richard | ▲ Buy | Open Market | 5,000 | $75K | 8/1/2025 |
| LSV Associates II, LLC | ▼ Sell | Other | 1,618,470 | — | 8/1/2025 |
| LSV Associates II, LLC | ▲ Buy | Open Market | 266,666 | $4.0M | 8/1/2025 |
| Blue David Lawrence | ▼ Sell | Other | 43,937 | — | 8/1/2025 |
| Sidow Kevin K. | ▼ Sell | Other | 12,344 | — | 8/1/2025 |
| Sidow Kevin K. | ▲ Buy | Grant | 7,666 | $0 | 8/1/2025 |
| Pardo Geoffrey B | ▼ Sell | Other | 2,280,482 | — | 8/1/2025 |
| Pardo Geoffrey B | ▲ Buy | Open Market | 100,000 | $1.5M | 8/1/2025 |
| Pardo Geoffrey B | ▲ Buy | Grant | 7,666 | $0 | 8/1/2025 |
| Ahearn Matthew Fraser | ▼ Sell | Other | 67,242 | — | 8/1/2025 |
| Paul Buckman | ▼ Sell | Other | 6,198 | — | 8/1/2025 |
| Paul Buckman | ▲ Buy | Grant | 7,666 | $0 | 8/1/2025 |
| Casey M. Tansey | ▼ Sell | Other | 1,686,403 | — | 8/1/2025 |
| Casey M. Tansey | ▼ Sell | Other | 85,587 | — | 8/1/2025 |
| Casey M. Tansey | ▼ Sell | Other | 921,131 | — | 8/1/2025 |
| Casey M. Tansey | ▲ Buy | Grant | 7,666 | $0 | 8/1/2025 |
| Casey M. Tansey | ▲ Buy | Open Market | 40,000 | $600K | 8/1/2025 |
| Points Jeffrey S. | ▲ Buy | Open Market | 50 | $750 | 8/1/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Shoulder Innovations Q2 2026 earnings and BTIG target raise
Shoulder Innovations held its Q2 2026 earnings conference call, where management discussed the quarter’s results. BTIG analyst kept its rating on the stock and increased the price target to $27. The new target is above the current average analyst estimate of $26.25 and above the 52‑week high of $24.59.
Shoulder Innovations Q2 2026 earnings and BTIG target raise. Shoulder Innovations held its Q2 2026 earnings conference call, where management discussed the quarter’s results. BTIG analyst kept its rating on the stock and increased the price target to $27. The new target is above the current average analyst estimate of $26.25 and above the 52‑week high of $24.59.